Stay updated on RO6874281 for HER2-positive Cancer: Clinical Trial
Sign up to get notified when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.

Latest updates to the RO6874281 for HER2-positive Cancer: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check15 days agoChange DetectedA banner announces NIH website changes, stating that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and that both terms may appear during the transition.SummaryDifference0.3%

- Check22 days agoChange DetectedThe website footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check29 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check50 days agoChange DetectedThe history shows the revision label updated from v3.6.6 to v3.7.0, indicating a platform or UI update. This does not alter the study data or substantive content of the record.SummaryDifference0.0%

- Check71 days agoChange DetectedA new revision label, v3.6.6, was added and the previous v3.6.5 was removed. This updates the record's metadata to reflect the latest version.SummaryDifference0.0%

Stay in the know with updates to RO6874281 for HER2-positive Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.